Oxurion

About:

Oxurion is a biotech drug development company focused on developing therapies for retinal disorders, now focusing on diabetic eye diseases.

Website: http://www.oxurion.com

Twitter/X: oxurion

Top Investors: Atlas Special Opportunities, Atlas Capital Markets, Epacria Capital Partners, Bareldam

Description:

Oxurion (Euronext Brussels: OXUR) is a biopharmaceutical company developing next generation standard of care ophthalmic therapies, which are designed to better preserve vision in patients with retinal vascular disorders including diabetic macular edema (DME), the leading cause of vision loss in diabetic patients worldwide, as well as other conditions, including wet age-related macular degeneration (AMD) and retinal vein occlusion (RVO).